To confirm altered perfusion within tibial bone marrow lesions (BMLs) and improve our understanding on 3 the relationship between BMLs and pain in knee osteoarthritis (OA). 4 5 METHODS 6
Participants with moderate to severe knee OA were recruited and pain was assessed using the pain 7 subscale of the WOMAC. Subchondral tibial BMLs were identified and graded on MRI PDW fat suppressed 8 images. A pharmacokinetic model was used to analyse perfusion parameters on dynamic contrast 9 enhanced MRI which represent transfer rates in and out of the BMLs. The relation between perfusion and 10 pain was evaluated using multivariable linear regression after adjustment for BML grade, age, gender and 11 BMI. 12 13 14 RESULTS 15
There were 37 participants (mean age 64.9 years, range 46 to 86) with radiographic Kellgren and Lawrence 16 grades of 3 and 4 in the study knee; 75.6% had BMLs that were classified grades 1 and 2. The mean 17 WOMAC pain score was 10.3 (0-20 scale). There was a significant correlation between BML Kel (rate of 18 contrast elimination) and BML grade (p=0.001 univariate, p=0.002 multivariate analyses), although we did 19 not demonstrate any significant multivariate association between BML perfusion and pain. We also found 20 an inverse relationship between pain at sleep and BML grade (p<0.05). 21 22 23 CONCLUSIONS 24
The absence of any significant association between bone perfusion and pain implies that the relationship of 25 tibial BMLs to pain in OA is still incompletely understood. BMLs are just one component of the whole knee 26 joint and are formed from various causes, all of which interact and collectively contribute to the genesis of 27 pain in OA. 28
INTRODUCTION 1
Osteoarthritis (OA) is the most common joint disease in modern, aging societies and causes substantial 2 physical and psychosocial disability(1). The risk for disability (defined as needing help walking or climbing 3 stairs) attributable to knee OA is as great as that attributable to cardiovascular disease and greater than 4 that due to any other medical condition in elderly persons (1). OA occurs when the dynamic equilibrium 5 between the breakdown and repair of joint tissues is overwhelmed by a combination of genetic, metabolic 6 and hormonal factors interacting with local biomechanical forces (2). This progressive joint failure may 7 cause pain, physical disability, and psychological distress (1), although many persons with structural and 8 radiological changes consistent with OA are asymptomatic (3). The reasons why there is this disconnect 9 between disease severity and the level of reported pain and disability is unknown. In advanced OA, pain 10 can be present with progressively less activity eventually occurring at rest or nocturnally. 11
The source of pain in OA is best framed in a biopsychosocial framework (posits that biological, 12 psychological and social factors all play a significant role in pain in OA) (4). The structural determinants 13 (part of the biological determinants) of pain and mechanical dysfunction in OA are also not well 14 understood, but are believed to involve multiple interactive pathways. One important source of nociceptive 15 input is the subchondral bone. During the initiation and progression of OA, subchondral bone is the site of 16 numerous dynamic morphological transformations due to an altered osteoblast metabolism, which is part 17 of the pathological process (5). These in situ structural changes in subchondral bone can be readily 18 observed using imaging techniques such as MRI during the course of OA. 19
On MRI, subchondral bone marrow signal alterations are characterized by ill-defined subchondral areas of 20 high signal intensity on T2 (T2w)-or proton density-weighted (PDw) fat suppressed (FS) fast spin echo (FSE) 21 or short tau inversion recovery (STIR) images (5). These bone marrow lesions (BMLs) play an integral if not 22 pivotal role in the symptoms that emanate from knee OA and its structural progression (6). More recently 23 their relation to pain severity was also demonstrated (7). These oedema-like lesions gradually increase in 24 size over time and their presence in subchondral bone marrow has been associated with increased bone 25 turnover indices as well as structural deterioration in knee OA (8;9). After intravenous administration of 26 contrast agents, enhancement of these signal alterations is evident, indicating hypervascularity and repair 27 activity (10;11). Contrast kinetics of small molecular agents in bone result from a combination of both 28 perfusion and permeability effects (12) . These combined effects shall be referred to as properties of bone 29 perfusion in this study. 30
Another bone-related cause of pain is bone angina due to decreased blood flow and elevated intraosseous 31 pressure (13). It has been suggested that OA has early vascular components that change underlying bone 32 perfusion in the affected bone(14). Although the presence of BMLs is strongly associated with the progression and pain in OA, the particular 7 bone pathology most responsible for pain remains elusive. Identifying this would be a major advance in 8 delineating appropriate therapeutic targets. 9
The aims of this study are to confirm our preliminary data demonstrating altered perfusion within tibial 10 BMLs (20) and to improve our mechanistic understanding of why tibial BMLs are related to pain by 11 examining the relationship between tibial BML size and perfusion as well the association between tibial 12 BML perfusion to pain severity and pain at rest or sleep. 13
METHODS 14

Study Sample 15
We conducted a pilot study to examine the objectives. We recruited 37 participants (age range: 46 to 86 16 years, BMI range 21.4 to 35.2) with knee OA who were on a waiting list for total knee replacement (TKR). 17
Participants had skyline and bilateral standing AP radiographs during the screening phase. The 18 radiographic Kellgren and Lawrence grade in the knees of participants ranged from grades 3 to 4. Exclusion 19 criteria included pregnant women, those who were having a revision knee replacement instead of a 20 primary knee replacement, a contraindication for MRI scans and those with an allergy to the contrast agent 21 gadolinium. Any patient with an underlying pathophysiology that could possible influence pain beyond the 22 impact of OA alone (such as RA, infection, gout, or neuropathic disorders) was also excluded. The 23 institutional review board of New England Baptist Hospital approved the study. Informed consent was 24 obtained from all study participants. 25
Assessment of symptoms 26
Pain was assessed using the pain subscale of the Likert version of the Western Ontario and McMaster 27
Universities Arthritis Index (WOMAC) (21) . This disease-specific measure is reliable, valid and responsive 28 and consists of 5 pain items, 17 function items and 2 stiffness items using a 5-point scale to score each 29 item, where higher scores indicate worse symptoms. Five categories of pain (walking on flat surface, going 30 up or down stairs, pain present at night while in bed, sitting or lying or standing upright) were assessed 31 separately with a 5-point scale from 0 (no pain) to 4 (most severe pain). Each score was then summed to 32 create a total pain score (range 0 to 20).Pain scores at night while sleeping range from 0 (none) to 3 33 (severe). 34
MRI Acquisition 35
Subjects had an MRI performed of their study knee prior to TKR (within 2 weeks of their surgery date) on a 1 1.5 Tesla scanner with a dedicated 8-channel extremity coil (1.5T Twin Speed Excite scanner (GE 2 Healthcare, Waukesha, WI)). The MR exam consisted of an axial and sagittal proton density weighted 3 (PDW) fat suppressed series and a high resolution coronal T1-Weighted 3D spoiled gradient echo (SPGR) 4 acquisition with water excitation. The following imaging sequences were used for BML localization on each 5 patient: both Axial and Sagittal PDW fat suppressed with TR/TE (echo time) of approximately 3550 ms and 6 20-30 ms respectively. Acquisition parameters of 3 mm slices, no skip/gap, 320 X 224 matrix, flip angle 90 7 degrees, receiver bandwidth (RCV BW) 31.25, 15 cm FOV (for distal femur and proximal tibia) for a total 8 acquisition time of 4.5 minutes. 9
Gd-DTPA was injected at a peripheral intravenous site at a standard concentration of 0.1 mmol per 10 kilogram using a power injector followed by a saline flush. Dynamic contrast enhanced (DCE) MRI was 11 performed using a sagittal 3D T1-weighted fast spoiled gradient echo (FSPGR) sequence with 20 sagittal 12 slices of 3 mm thickness over 7 minutes with a 7.5 second time resolution. During data acquisition, the TR 13 was 6.6 and TE was 1.7 with a 12 degree flip angle, RCV BW 50, a 12 cm field of view and a 256 x 128 14 matrix. 15
MRI Analysis 16
Subchondral BMLs were initially identified on both axial and sagittal PDW fat suppressed images. As the 17 focus of this analysis is on tibial BMLs the largest tibial BML was scored. This region was utilized for DCE-18
MRI perfusion analysis and defined as discrete areas of increased signal adjacent to subcortical bone. Each 19 BML was graded from 0-3 on the basis of lesion size according to the BLOKS scoring system (22 We assessed the relation between perfusion parameters in BML with WOMAC pain and night pain 11 (dependent variable-one item from WOMAC pain subscale). These were adjusted with their respective 12 muscle variables as internal control. The relation between perfusion and WOMAC pain was assessed using 13 a linear regression model, assuming the normal distribution of WOMAC pain score. Pain score at night 14 while sleeping was categorized into three levels from none (0 or 1), to moderate (2), to moderate or more 15 (3), and ordinal logistic regression model was performed to test its relationship with BML perfusion. The 16
proportional odds assumption inherent in the ordinal logistic regression model will was tested first. A non-17 significant test result was taken as the evidence that this assumption was met and the odds ratios from the 18 model was interpreted as the odds of being "lower" or "higher" on the response variable across the entire 19 range of the outcome. The relation of BML grade to perfusion and pain at night were also assessed, with 20 linear regression for the former and ordinal logistic regression for the latter, respectively. 21
For each model, the unadjusted and adjusted estimated values, along with 95% confidence interval (95%CI) 22 and p-values were reported. Analyses were conducted with SAS v9.2, SAS Institute, Cary, NC.P<0.05 with 23 two-sided test was considered statistically significant. 24
RESULTS
25
The characteristics of the participants in this study are shown in Table 1 . A total of 37 subjects (21 females  26 and 16 males) with a mean age of 64.9 years and a mean BMI in the overweight category of 28.9 kg/m 2 .
27
The mean WOMAC pain score was 10.2 (0-20 scale) which indicates a study population with moderate pain 28 severity. The majority (75.6%) had BMLs that were classified grades 1 and 2 according to lesion size. The 29 median no. of tibial bone marrow lesions was 2 (range 1-5). The largest BML (maximum grade) was 30 selected for DCE analysis. 31 32 We also assessed the relation between BML perfusion and pain at night ( tissue is continuous with the vascular channels which invade the articular cartilage in BMLs and are 5 associated with knee pain (27). The contribution of angiogenesis to pain enables the innervation of tissues 6 and may synergise with inflammation to exacerbate pain (28). 7  BML perfusion is not associated with pain after adjusting for important covariates. 8
The failure to find an association of bone perfusion with pain is of interest and suggests that perfusion of 9
BMLs does not contribute to their pain genesis. Other studies also allude that knee pain stems from many 10 other causes and even though BMLs are associated with pain in OA, this association with pain is significant 11 only in the presence of other abnormal articular changes. Torres et al(29) agreed that BMLs alone were not 12 sufficient to account for pain and its contribution to pain severity appeared to require the presence of 13 other modifications such as capsular distention and bone attrition. Attrition of bone is a more common 14 finding in people with knee pain and OA than those with OA without knee pain (30). By the time a patient 15 experiences pain and has evidence of OA on MRI, many other pathologic features such as synovitis, 16 synovial effusions and cysts coexist which makes it challenging to identify the single feature that causes the 17 most pain (31). 18
There have also been studies that did not find any association between BML size and pain in OA (32;33). An 19 attempt to reconcile these data could be that the presence of BML and altered perfusion may only signal an 20 element of susceptibility for the induction of pain whose expression still required additional structural 21 abnormalities within the knee (34). Moreover, BMLs Grades 1 and 2 had small volumes compared to the 22 total joint volume and may not contribute to the overall knee pain. 23
We did find a positive association of BML K ep and pain at night suggesting a potential relationship between 24 the permeability of the BMLs and nocturnal pain. The underlying mechanism for this relationship is unclear 25 and would be worth investigating in future studies to see if this can be replicated. 26
 Trend to inverse correlation between pain at night and BML Grade 27
Larger BMLs have been shown to be associated with higher grades of cartilage defects (9) and one would 28 again expect increasing BML size to be associated with greater pain scores. This was therefore a result that 29
was contrary to what we hypothesised. 30
There are two possible explanations for this unexpected finding. Firstly, it is not clear if BMLs exhibit a 31 homogenous expression in all patients. Previous histopathological studies have demonstrated that the 32
BMLs themselves consist of a mixed pathology including granulation, diffuse necrosis, fibrinoid deposition 33 and blood vessel wall hyperplasia (19). In addition, histologically it has also been reported that only 4% of 34
BMLs contained edema and that they consisted of other irregularities such as marrow fibrosis and 35 trabecular remodeling (18;35). Pain initiation from BML abnormalities emanate from the fact that necrotic 36 cells release neuromediators(34). It will therefore also be of interest to ascertain the degree and amount of 37 necrosis within these BMLs to determine if size does also correlate with necrosis. In light of these, the BMLs 1 in our study participants may not have been homogeneously edematous and that other characteristics 2 within the whole knee joint may also be responsible for the induction of pain. 3
There are several limitations of the study that require mentioning. Firstly, we evaluated the association of 4
BMLs and pain of the entire knee. Differences in the compartmental BMLs and their relation to pain at their 5 respective anatomical sites were therefore not examined. The second limitation was that we did not take 6 into account that in addition to BMLs and altered perfusion, there are multiple joint structures within the 7 knee such as subchondral bone cysts and synovitis that could also have contributed to knee pain. Future 8 research into this area could include patient subgroups with other subchondral bone pathology that may 9
shed more light on their relationship with bone perfusion and pain in OA. Another limitation was the lack of 10 concomitant information regarding OA treatments the participants may currently be receiving or have 11 received previously such as chondroitin, hyaluronate and physiotherapy which could have affected the size 12 of BML, pain, fluid dynamics and bone perfusion. In future studies it would also be important to have 13 histologic correlation and a broader sample representing different stages of disease severity and not just 14 those with end-stage disease. It is possible that the central region on which the DCE MRI was assessed may 15 have different angiogenic activity and contrast uptake to the rim of enhancement in the periphery seen on 16 the fat suppressed sequence. Future studies should extend our findings to include the whole BML and 17 other regions of the joint including the femur. 18
To conclude, osteoarthritis is a dynamic disease process with interconnecting symptoms and structural 19 changes. Even though there is increasing evidence that BMLs play an important part in the pathogenesis of 20 knee OA, BMLs are formed from various causes, all of which may be interacting and complex and comprise 21 of biomechanical, genetic and inflammatory components, of which bone perfusion is only one aspect. The 22 mixed results in our study imply that the pathological and functional significance of tibial BMLs in relation 23 to pain is still a matter of debate. Ascertaining which structures in the knee with OA are associated with 24 pain will aid our understanding of the pathophysiology of OA and lead to the development of more 25 effective therapeutic options to delay disease progression. 26 Table 1 Baseline demographics of study population (n=37) 
